Krebs Biochemicals Industries Ltd vs Sudeep Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Krebs Biochemicals & Industries Ltd is ₹ 58.92 as of 04 May 10:16 . The P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Sudeep Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Sudeep Pharma Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The revenue of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sudeep Pharma Ltd for the Dec '25 is ₹ 179.17 crore as compare to the Sep '25 revenue of ₹ 172.83 crore. This represent the growth of 3.67% The ebitda of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sudeep Pharma Ltd for the Dec '25 is ₹ 66.81 crore as compare to the Sep '25 ebitda of ₹ 65.63 crore. This represent the growth of 1.8% The net profit of Krebs Biochemicals & Industries Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sudeep Pharma Ltd changed from ₹ 17.08 crore to ₹ 47.7 crore over 7 quarters. This represents a CAGR of 79.84% The Dividend Payout of Krebs Biochemicals & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sudeep Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.

About Sudeep Pharma Ltd

Sudeep Pharma Limited was incorporated as Sudeep Pharma Private Limited' as a private limited company dated December 21, 1989, issued by the Registrar of Companies, Ahmedabad.
Thereafter, Company was converted into a public limited company and the name of the Company was changed to Sudeep Pharma Limited' pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra & Nagar Haveli.
Company was subsequently converted back to a private limited company vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of Company was accordingly changed from Sudeep Pharma Limited' to Sudeep Pharma Private Limited'.
Further, Company was converted into a public limited company and consequently, the name of Company was changed to Sudeep Pharma Limited'.

FAQs for the comparison of Krebs Biochemicals & Industries Ltd and Sudeep Pharma Ltd

Which company has a larger market capitalization, Krebs Biochemicals & Industries Ltd or Sudeep Pharma Ltd?

Market cap of Krebs Biochemicals & Industries Ltd is 129 Cr while Market cap of Sudeep Pharma Ltd is 7,997 Cr

What are the key factors driving the stock performance of Krebs Biochemicals & Industries Ltd and Sudeep Pharma Ltd?

The stock performance of Krebs Biochemicals & Industries Ltd and Sudeep Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Krebs Biochemicals & Industries Ltd and Sudeep Pharma Ltd?

As of May 4, 2026, the Krebs Biochemicals & Industries Ltd stock price is INR ₹60.12. On the other hand, Sudeep Pharma Ltd stock price is INR ₹708.1.

How do dividend payouts of Krebs Biochemicals & Industries Ltd and Sudeep Pharma Ltd compare?

To compare the dividend payouts of Krebs Biochemicals & Industries Ltd and Sudeep Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.